https://www.vccircle.com/caninvascentmo-alts-beat-the-benchmark-as-portfolio-firm-readies-for-ipo
Can InvAscent, MO Alts beat the benchmark as portfolio firm readies for IPO?
Mid-market private equity firms InvAscent and Motilal Oswal Alternates (MO Alts) are planning to monetize their investments in a healthcare company they...
portfolio firminvascentmoalts
https://www.vccircle.com/bottomlineinvascent-backed-malladi-drugs-fy25-revenue-profit-fall-amid-ipo-plans
Bottomline: InvAscent-backed Malladi Drugs' FY25 revenue, profit fall amid IPO plans
InvAscent-backed bulk drugs maker Malladi Drugs and Pharmaceuticals Ltd reported a decline in both revenue and net profit in the financial year ended...
revenue profitbottomlinedrugs